21 October 2021 - BEAM AllianceHow the EU Pharmaceutical Strategy could help prevent the next pandemicVideo recordings of BEAM’s Roundtable. Discussion with EC officials and experts on the AMR initiatives of the EU Pharmaceutical Strategy.read more >>
27 September 2021 - BEAM AllianceBEAM Alliance wants HERA to effectively support R&D in antimicrobial resistanceBEAM Alliance welcomes the HERA proposal but urges EU Member States to recognise the importance of early-stage support for Research…read more >>
07 September 2021 - BEAM AllianceAntimicrobial resistance: the silent pandemicIt is necessary to support R&D with ad hoc funding (so-called PUSH incentives), but above all to set up market…read more >>
22 January 2021 - BEAM AllianceBEAM Alliance Joined The One Health Good Practices For The Successful Management Of Antimicrobial ResistanceThe BEAM Alliance decided to join the Call To Action of the AMR Stakeholder Network, supported by the European Public…read more >>
18 November 2020 - BEAM Alliance2020 Antimicrobial Resistance campaign: How to change the fight against AMR?The BEAM Alliance recently worked with Global Cause on the 2020 Antimicrobial Resistance campaign.read more >>
09 November 2020 - BEAM AllianceAntibiorésistance : Anticiper une nouvelle crise sanitaireFlorence Séjourné, présidente de BEAM Alliance : « Il faut anticiper les investissements en R&D dès maintenant pour avoir un…read more >>
04 October 2021 - Nabriva Therapeutics GmbHNabriva Publishes Data Demonstrating the Potent Anti-Inflammatory Properties of XENLETA® (lefamulin)XENLETA® (lefamulin) is a first-in-class semi-synthetic pleuromutilin antibiotic for systemic administration in humans discovered and developed by the Nabriva Therapeutics…read more >>
22 September 2021 - NovaBiotics LtdNovaBiotics publishes further data on the mechanism of action of its candidate NM001 therapy (Lynovex) for cystic fibrosis (CF)NovaBiotics Ltd is a leading clinical-stage biotechnology company focused on leveraging its novel immunology platforms to design and develop first-in-class…read more >>
10 September 2021 - AdjuTec Pharma ASAdjuTec Pharma Strengthens the Patent PortfolioAdjuTec Pharma is a Company that is dedicated to developing and providing novel antibiotic resistance breakers to the global market.…read more >>
10 September 2021 - IHMA Europe SarlIHMA is looking for a Laboratory Manager Specialty & MolecularIHMA is one of the world’s most dynamic central reference laboratories, specializing in the field of anti-infectives. We serve the…read more >>
10 September 2021 - Polyphor LtdPolyphor and EnBiotix announce closing of purchase agreement of Inhaled Murepavadin by EnBiotixPolyphor is a research-oriented Swiss biopharmaceutical company with a leading macrocyclic peptide technology platform. Polyphor is headquartered in Allschwil near…read more >>
08 September 2021 - Nabriva Therapeutics GmbHNabriva: Lefamulin Receives Approval in Taiwan for Treatment of Community-Acquired PneumoniaNabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections.…read more >>
10 January 2022Biotech Showcase 2022 (In-person & Virtual Event)Engage with Global investors & Life Sciences Executives! Join us from January 10–12, 2022 in San Francisco, or Join us…read more >>
09 December 2021SCT Virtual Symposium: On the hunt for next generation antimicrobial agentsAn exciting two-day symposium entitled: On the hunt for next generation antimicrobial agents. This symposium will bring together some of…read more >>
23 November 2021Phage futures Europe: Translating phage-based applications into clinically and commercially viable therapeuticsSeeing the news that Proteon Pharmaceuticals secured a €21 million investment was an exciting moment. It is another backing in…read more >>
17 November 20216th Annual Microbiome Connect: Gut TherapeuticsThis event is a unique gathering of individuals from academia and industry who are collaborating to advance microbiome science.read more >>
15 November 20213rd SCI-RSC symposium on antimicrobial drug discoveryCoinciding with WHO’s World Antibiotics Awareness week, this two-day meeting will examine the latest advances in antimicrobial drug discovery from…read more >>
25 October 2021BIO-Europe® 2021 Digital – 27th Annual International Partnering ConferenceThe international BIO-Europe® 2021 gathering will be held digitally, providing certainty, in this time of insecurity, to execute its pivotal…read more >>
22 October 2021European Celebration of 5 Years of Progress with CARB-X: A virtual discussion of progress and plans to accelerate innovation globallyA virtual discussion of the critical role that CARB-X and its global partners play in driving the development of innovative…read more >>
21 October 2021REVIVE Webinar: Biofilms: What are they and why do we care?REVIVE is a space for everybody with an interest in antimicrobial R&D. The Global Antibiotic Research and Development Partnership (GARDP)…read more >>
16 October 20215th International Course on Antibiotics and Resistance (ICARe)The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is…read more >>
